Topical tacrolimus and cancer (continued). Do not use.
D000287:Administration, Topical; D000075202:Contraindications; D003876:Dermatitis, Atopic / Q000188:drug therapy; D005602:France; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced*; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D016559:Tacrolimus